相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
A. Traboulsee et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol
Dragan A. Stojanov et al.
EUROPEAN RADIOLOGY (2016)
Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
Peter Alping et al.
ANNALS OF NEUROLOGY (2016)
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
Massimo Filippi et al.
LANCET NEUROLOGY (2016)
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Mike P. Wattjes et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Mike P. Wattjes et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Increasing prevalence of multiple sclerosis in Vasterbotten County of Sweden
A. Svenningsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring
Anthony Traboulsee et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2015)
Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy
Angela Vidal-Jordana et al.
JOURNAL OF NEUROLOGY (2015)
OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol
F. Cotton et al.
JOURNAL OF NEURORADIOLOGY (2015)
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process
Alex Rovira et al.
NATURE REVIEWS NEUROLOGY (2015)
EVIDENCE-BASED GUIDELINES MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients
Mike P. Wattjes et al.
NATURE REVIEWS NEUROLOGY (2015)
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
Robert J. McDonald et al.
RADIOLOGY (2015)
MRI pattern in asymptomatic natalizumab-associated PML
Mike P. Wattjes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Progressive Multifocal Leukoencephalopathy after Natalizumab Discontinuation
Andrew J. Fine et al.
ANNALS OF NEUROLOGY (2014)
Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
A changing treatment landscape for multiple sclerosis: challenges and opportunities
F. Piehl
JOURNAL OF INTERNAL MEDICINE (2014)
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Christian Confavreux et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
High Nationwide Incidence of Multiple Sclerosis in Sweden
Cecilia Ahlgren et al.
PLOS ONE (2014)
High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material
Tomonori Kanda et al.
RADIOLOGY (2014)
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis
Omar Khan et al.
ANNALS OF NEUROLOGY (2013)
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
Henrik S. Thomsen et al.
EUROPEAN RADIOLOGY (2013)
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients
Massimo Filippi et al.
NEUROLOGICAL SCIENCES (2013)
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic
Ebru Erbayat Altay et al.
JAMA NEUROLOGY (2013)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Incidence of Immediate Gadolinium Contrast Media Reactions
Martin R. Prince et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
High nationwide prevalence of multiple sclerosis in Sweden
C. Ahlgren et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Relapses in multiple sclerosis are age- and time-dependent
H. Tremlett et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Factors influencing quality of life in multiple sclerosis patients:: disability, depressive mood, fatigue and sleep quality
IS Lobentanz et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis
NC Silver et al.
JOURNAL OF NEUROLOGY (2001)
分享论文
